Next |
home / stock / clsd / clsd message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: $CLSD 26% v2,3M C1.35 f61,364M H1.48 ML.9 RL1.03 | znewcar1 | investorshangout | 04/04/2023 8:26:00 PM |
Here we go | heyitsmeagain | investorshub | 08/10/2022 6:31:55 PM |
Loaded for this runner. Wish I had more loot. | heyitsmeagain | investorshub | 08/10/2022 5:38:09 PM |
Hard to Borrow is back on $CLSD today | BBANBOB | investorshub | 04/20/2022 1:29:09 PM |
FYI THE HARD TO BORROW classification(at Schwab) just went | BBANBOB | investorshub | 04/19/2022 2:23:39 PM |
Well so far so good !!!!!!!!!!!!!!!!!! Let's say | BBANBOB | investorshub | 03/30/2022 3:32:05 PM |
Well well let's give this news 2-3 days | BBANBOB | investorshub | 03/28/2022 2:57:59 PM |
Now that would be perfect. Id hire me | jhdf51 | investorshub | 03/16/2022 3:04:04 PM |
Again Earnings was a beat and they were .31 | BBANBOB | investorshub | 03/16/2022 2:57:54 PM |
Yes I agree. Definitely could be. Dang Price | jhdf51 | investorshub | 03/16/2022 2:46:22 PM |
I'll take $9 for this year, but still | BBANBOB | investorshub | 03/16/2022 1:11:35 PM |
I see $9. $18 was last year. | jhdf51 | investorshub | 03/16/2022 7:03:04 AM |
But all companies good or bad always have | BBANBOB | investorshub | 03/15/2022 2:46:12 PM |
SHORTS Again as I did last week, I would | BBANBOB | investorshub | 03/15/2022 2:02:07 PM |
Having NOT been able to take part in | BBANBOB | investorshub | 03/15/2022 1:58:14 PM |
Well YET AGAIN it seems my 3 day | BBANBOB | investorshub | 03/15/2022 1:53:55 PM |
CRUDEOIL I have always suggested on these boards that, | BBANBOB | investorshub | 03/14/2022 3:38:47 PM |
OH I agree 100% and suggested that ALL | BBANBOB | investorshub | 03/13/2022 5:48:07 PM |
Good earnings, & good technical indicators > $CLSD | crudeoil24 | investorshub | 03/13/2022 5:43:10 PM |
YEPPERS and so we have 4 months left | BBANBOB | investorshub | 03/13/2022 5:40:02 PM |
News, Short Squeeze, Breakout and More Instantly...
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
ALPHARETTA, Ga., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that its third quarter 2024 financial...
- CLS-AX Phase 3 Ready Based on Positive Phase 2b Topline Data in Wet AMD - - Differentiated Profile for CLS-AX Targeting Flexible Dosing Similar to a Biologic with the Potential Extended Duration of a Tyrosine Kinase Inhibitor (TKI) - - Versatility of SCS Microinjector ...
- Maintained Stable Visual Acuity and Anatomical Control Over 9 Months - - Positive Safety Profile with No Ocular or Treatment-Related Serious Adverse Events - - 67% of CLS-AX Participants Did Not Require Any Additional Treatment up to 6 Months - - Reduced Treatment Burd...